1-9 of 9
Brian Van Ness, Ph.D
Close
Sort by
Journal Articles

Strategies To Identify Effective Treatments For Proteasome Inhibitor Resistant Multiple Myeloma

Brian Van Ness, Ph.D, Holly A. F. Stessman, Ph.D., Linda B. Baughn, Ph.D., Aatif Mansoor, Amit Mitra, Nathan G. Dolloff, PhD, Chad L. Myers, PhD, Fenghuang Zhan, MD&PhD, Taylor Harding, B.S.
Journal: Blood
Blood (2013) 122 (21): 278.
https://doi.org/10.1182/blood.V122.21.278.278
Published: 2013
Journal Articles

Low Expression of CXCR4 in Bortezomib-Resistant Multiple Myeloma Correlates with Extramedullary Disease in a Murine Mouse Model

Holly A. F. Stessman, Aatif Mansoor, Fenghuang Zhan, MD, PhD, Guido J. Tricot, MD, PhD, John Sunderland, PhD, Susan A. Walsh, Siegfried Janz, M.D., Brian Van Ness, Ph.D., Linda B. Baughn, Ph.D.
Journal: Blood
Blood (2012) 120 (21): 442.
https://doi.org/10.1182/blood.V120.21.442.442
Published: 2012
Journal Articles

In Silico Prediction of Novel Drug Combinations to Combat Bortezomib-Resistant Multiple Myeloma

Holly A. F. Stessman, Tian Xia, PhD, Aatif Mansoor, Raamesh Deshpande, Linda B. Baughn, Ph.D., Chad L. Myers, PhD, Nathan G. Dolloff, PhD, Brian Van Ness, Ph.D.
Journal: Blood
Blood (2012) 120 (21): 1344.
https://doi.org/10.1182/blood.V120.21.1344.1344
Published: 2012
Journal Articles

Expression of Germinal Center B Cell Markers in Bortezomib-Resistant Multiple Myeloma Cells

Holly Stessman, Linda B. Baughn, Ph.D., Aatif Mansoor, Brian Van Ness, Ph.D.
Journal: Blood
Blood (2011) 118 (21): 129.
https://doi.org/10.1182/blood.V118.21.129.129
Published: 2011
Journal Articles

Modeling Proteasome Inhibition in Lymphoma

Linda B. Baughn, Ph.D., Holly Stessman, Aatif Mansoor, Brian Van Ness, Ph.D.
Journal: Blood
Blood (2011) 118 (21): 4946.
https://doi.org/10.1182/blood.V118.21.4946.4946
Published: 2011
Journal Articles

Good and Poor Response Gene Expression Signatures to Proteasome Inhibitors Using a Mouse Model of Multiple Myeloma

Holly Stessman, Linda B. Baughn, Ph.D., Aaron G. Sarver, Ph.D., Aatif Mansoor, Tzu G. Wu, Ph.D., Siegfried Janz, M.D., Brian Van Ness, Ph.D.
Journal: Blood
Blood (2011) 118 (21): 1843.
https://doi.org/10.1182/blood.V118.21.1843.1843
Published: 2011
Journal Articles

Identification of Single Nucleotide Polymorphism Interactions Associated with Survival and Risk In Multiple Myeloma Using Novel Data Mining Methods

Brian Van Ness, Ph.D., Majda Haznadar, Ph.D., Gang Fang, Wen Wang, Vanja Paunic, Michael Steinbach, Vipin Kumar, Ph.D., Patrick Day, Johnson David, Gareth J Morgan, MD, PhD, Bart Barlogie, MD, PhD, Brian GM Durie, MD
Journal: Blood
Blood (2010) 116 (21): 2973.
https://doi.org/10.1182/blood.V116.21.2973.2973
Published: 2010
Journal Articles

Associations of DNA Repair Gene Polymorphisms in XRCC1 and ERCC2 with Clinical Outcome in ECOG Trial E9486.

Brian Van Ness, Ph.D., Emily Blood, Ph.D., Philip Greipp, M.D., Neil Kay, M.D., Vincent Rajkumar, M.D., Robert Kyle, M.D., Martin Oken, M.D., Rafael Fonseca, M.D., Fangyi Zhao, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1475.
https://doi.org/10.1182/blood.V104.11.1475.1475
Published: 2004
Journal Articles

Genetic Polymorphisms Associated with Clinical Outcome in the Intergroup Trial S9321, Comparing High Dose Therapy with Standard Dose Therapy for Myelomaon, on Behalf of ECOG, SWOG, CALGB, and the Bank on a Cure.

Rafael Santana-Davila, M.D., John Crowley, Ph.D., Brian Durie, M.D., Bart Barlogie, M.D., Philip Greipp, M.D., Brian Van Ness, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1495.
https://doi.org/10.1182/blood.V104.11.1495.1495
Published: 2004